A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/2011
11/15/2011	US8058253 Growth hormone releasing hormone treatment to decrease cholesterol levels
11/15/2011	US8058249 Immunostimulatory nucleic acid molecules
11/15/2011	US8058248 Foot and mouth disease virus vaccine comprising interferons
11/15/2011	US8058068 Covalent coupled of nucleic acids, peptides or proteins to active material for enhancing transfection efficiency; potentiation
11/15/2011	US8058061 Vector encoding human globin gene and use thereof in treatment of hemoglobinopathies
11/15/2011	US8058048 Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
11/15/2011	US8058028 Polynucleotide
11/15/2011	US8057997 Nucleic acid binding compounds containing pyrazolo[3,4-D]pyrimidine analogues of purin-2,6-diamine and their uses
11/15/2011	US8057824 Compositions for achieving a therapeutic effect in an anatomical structure and methods of using the same
11/15/2011	US8057821 Biodegradable cross-linked cationic multi-block copolymers for gene delivery and methods of making thereof
11/15/2011	US8057806 Viruses comprising mutant ion channel protein
11/15/2011	US8057162 vaccination directed against the hepatitis C virus (HCV);
11/15/2011	CA2518295C Methods of inducing the expression of bone morphogenetic proteins (bmps) and transforming growth factor-.beta. proteins (tgf-.beta.s) in cells
11/15/2011	CA2461989C Method for treating multiple myeloma
11/15/2011	CA2392877C Improvements in or relating to immune responses to hiv
11/15/2011	CA2372655C Recombinant adenovirus having low pre-existing neutralizing activity
11/15/2011	CA2365196C Chlamydia antigens and corresponding dna fragments and uses thereof
11/15/2011	CA2352537C Tgf.beta.1-inhibitor peptides
11/15/2011	CA2257851C Modulators of tissue regeneration
11/15/2011	CA2189349C Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms
11/15/2011	CA2170641C Senescent cell-derived inhibitors of dna synthesis
11/10/2011	WO2011140525A2 Methods and compositions related to a retinoid receptor-selective pathway
11/10/2011	WO2011140285A2 Combinations of tgfbeta and cox-2 inhibitors and methods for their therapeutic application
11/10/2011	WO2011140279A1 Aav-mediated subcellular targeting of heterologous rhodopsins in retinal ganglion cells
11/10/2011	WO2011139907A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases
11/10/2011	WO2011139846A2 Compositions and methods for reduced scarring and for treatment of fibrosis
11/10/2011	WO2011139387A1 Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt)
11/10/2011	WO2011139218A1 Nucleic acid delivery vehicle uses thereof
11/10/2011	WO2011137687A1 Antibody against carcinoembryonic antigen and uses thereof
11/10/2011	WO2011090741A3 TREATMENT OF TUMOR PROTEIN 63 (p63) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO p63
11/10/2011	WO2011090740A3 Treatment of nuclear respiratory factor 1 (nrf1) related diseases by inhibition of natural antisense transcript to nrf1
11/10/2011	US20110277184 Insecticidal proteins from bacillus thuringiensis
11/10/2011	US20110277045 Methods for increasing beta cell mass comprising administering a ra770 polypeptide
11/10/2011	US20110275156 Delivery of DNA or RNA Via Gap Junctions from Host Cells to Target Cells and a Cell-Based Delivery System for Antisense or siRNA
11/10/2011	US20110275155 Entrapped stem cells and uses thereof
11/10/2011	US20110275093 Novel use of adenoviruses and nucleic acids that code for said viruses
11/10/2011	US20110274719 Helicobacter system and uses thereof
11/10/2011	US20110274718 System for Modulating Expression of Hypothalmic Brain-Derived Neurotrophic Factor (BDNF)
11/10/2011	US20110274706 Nucleic acid delivery vehicle and uses thereof
11/10/2011	US20110274705 Methods and compositions to generate and control the effector profile of t cells by simultaneous loading and activation of selected subsets of antigen presenting cells
11/10/2011	US20110274702 Neutralizing anti-influenza a virus antibodies and uses thereof
11/10/2011	US20110274671 Human progenitor t-cells
11/10/2011	US20110274669 Therapeutic retroviral vectors for gene therapy
11/09/2011	EP2385124A2 Peptides or peptide analogues for modulating the binding of a PDZ protein and a PL protein
11/09/2011	EP2385123A1 MicroRNA molecules
11/09/2011	EP2385122A1 MicroRNA molecules
11/09/2011	EP2385117A1 HLA-A*3303-restricted WT1 peptide and pharmaceutical composition comprising the same
11/09/2011	EP2385058A1 Method for detecting the expression of a human endogenous retrovirus envelope protein and uses of a coding gene for said protein
11/09/2011	EP2385056A2 Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues
11/09/2011	EP2384202A1 A dominant negative mutants of sam68 for use in the treatment of spinal muscular atrophy (sma)
11/09/2011	EP1713511B1 Therapeutic agent for treatment of cancer comprising human apolipoprotein (a) kringles lk68 or lk8 genes as effective ingredient, and method for treating cancer using the same
11/09/2011	EP1693451B1 Method of growing myocardial cells
11/09/2011	EP1669450B1 Staple type oligonucleotide and drug comprising the same
11/09/2011	EP1664277B1 Method of preparation of pharmaceutically grade plasmid dna
11/09/2011	EP1328624B1 B7-like molecules and uses thereof
11/09/2011	EP1062337B1 Human n-type calcium channel isoform and uses thereof
11/09/2011	CN1422950B Recombinant gland-related virus expressing human blood angiotonin II receptor I antisense gene and preparation method thereof
11/09/2011	CN102239260A Treatment of apolipoprotein-a1 related diseases by inhibition of natural antisense transcript to apolipoprotein-a1
11/09/2011	CN102238967A Telomerase inhibitors and methods of use thereof
11/09/2011	CN102234687A Application of micro ribose nucleic acid (miRNA) or precursor thereof of inhibitor zinc finger protein Zinc finger and BTBdomain-containing protein 20 (ZBTB20)
11/09/2011	CN102234658A Target quaternary ammonium salt cationic polymer lipid gene carrier, preparation method and application thereof
11/09/2011	CN102234645A Artificially synthesized promoter for gene therapy and vaccine development
11/09/2011	CN102234638A Modified maize ribosome-inactivating protein precursor and application as well as protein purification method thereof
11/09/2011	CN102234634A High-transduction-efficiency hepatophilic cell hepatitis C virus pseudo-particle and envelope protein coded sequence thereof
11/09/2011	CN102233137A Recombinant plasmid DNA vaccine composition for treating Hepatitis B
11/09/2011	CN102233136A Recombinant plasmid vaccine for treating hepatitis B and composition thereof
11/08/2011	US8053558 Dendritic cell co-stimulatory molecules
11/08/2011	US8053421 DNA vaccines against tumor growth and methods of use thereof
11/08/2011	US8053420 Enhance cellular uptake of uncharged antisense oligonucleotide; forming a conjugate and arginine-rich peptide; oligonucleotide includes a string of contiguous guanine bases; substitute inosine base to limit the number of contiguous guanine bases to three; cancer, polycystic kidney disease, restenosis
11/08/2011	US8053414 Methods of using B7-DC molecules to induce or enhance an immune response
11/08/2011	US8053408 Methods for treating obesity using fibroblast growth factor-like polypeptides
11/08/2011	US8053231 Expression vector comprising nucleotide sequences coding inflammatory cytokine for use in prevention and treatment of inflammatory disorders
11/08/2011	US8053206 Antagonists of HMG1 for treating inflammatory conditions
11/08/2011	US8053183 Method of diagnosing esophageal cancer
11/08/2011	US8052975 Compounds and methods for treatment and diagnosis of chlamydial infection
11/08/2011	US8052967 Stable adenoviral vectors and methods for propagation thereof
11/08/2011	US8052966 gene therapy; producing targeted viral and non-viral particles delivery vectors for treating neoplastic disorders; retroviral, adenoviral, adeno-associated virus, Herpes Virus, and pseudotyped viruses, vesicular stomatitis virus G-protein (VSV-G), and to non-viral vectors that contain a viral protein
11/08/2011	US8052965 Viruses with enhanced lytic potency
11/08/2011	CA2653201C Compositions and uses of e3-gp19k for treating diabetes
11/08/2011	CA2459230C Peptidic compounds selectively binding to p-selectin
11/08/2011	CA2415399C Use of strains of the parapox ovis virus against organ fibrosis
11/08/2011	CA2247285C Human tumor necrosis factor delta and epsilon
11/03/2011	WO2011136369A1 Cationic lipid
11/03/2011	WO2011136368A1 Cationic lipid
11/03/2011	WO2011136233A1 Self-renewal promoter for neural stem cells and method for using same
11/03/2011	WO2011135905A1 Lipid membrane structure
11/03/2011	WO2011135531A2 MEDICAL DEVICES FOR DELIVERY OF siRNA
11/03/2011	WO2011135141A1 Modified oligonucleotides as regulators of gene expression
11/03/2011	WO2011135140A1 Method for the delivery of oligonucleotides
11/03/2011	WO2011135138A1 Lipophilic derivatives of nucleic acids
11/03/2011	WO2011135002A1 Gene trapping for use in gene therapy
11/03/2011	WO2011134439A1 Specific anti-viral antisense nucleic acid drug for avian influenza virus
11/03/2011	WO2011134084A1 Methods, compositions, and kits for the treatment of matrix mineralization disorders
11/03/2011	WO2011134063A1 Ccn3 and uses thereof against metabolic syndrome- associated disorders
11/03/2011	WO2011049346A3 Compositions for improving migration potential of stem cells
11/03/2011	WO2010133975A3 Reducible polyamino disulfides as transfectants
11/03/2011	WO2010118238A3 Controlled release devices and methods for delivery of nucleic acids
11/03/2011	US20110269950 PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS
11/03/2011	US20110269826 Method
11/03/2011	US20110269674 Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses

1 ... 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 ... 870